Vischer advised the main investors on the extension of Memo Therapeutics’ series C financing round, raising CHF20 million and bringing the total amount raised in the funding round to CHF 45m. Vischer’s team Vischer’s team comprised corporate / M&A partner Dr. Matthias Staehelin (pictured), corporate / M&A managing associate Vincent S. Reardon, corporate / M&A associate […]
Last June, the Swiss Competition Commission (ComCo) launched an investigation into Mastercard’s domestic card-present interchange fees for its Debit and Maestro debit card products. In the meantime, Mastercard has been able to reach an
Homburger advised UBS Switzerland in its capacity as mandated lead arranger, bookrunner and agent regarding BKW ‘s new CHF 1 billion law governed revolving credit facility, which has a five-year term until 2029, with the option to
Advestra advised Wille Finance, an international Swiss-based family office focusing on private equity / venture capital, real estate and listed assets, on its anchor investment in SwissComply, a provider of outsourcing solutions for
Walder Wyss advised the funds managed by Perceptive Advisor, a privately owned hedge fund sponsor investing in biotechnology and life sciences sectors, on the secured term loan financing for up USD 50,000,000 granted to Sophia Genetics,
Schellenberg Wittmer advised Emerald Technology Ventures, a venture capital firm focusing on sustainable industrial innovation, in obtaining its FINMA license as asset manager of collective assets with the Swiss Financial Supervisory Authority (FINMA). Emerald Technology
Wenger Vieli advised Progile, an AI company based in Zurich, on all Swiss legal matters concerning their recent funding round. This secured funding of CHF 1.3 million, which will serve to increase the development and distribution
Walder Wyss advised the funds managed by Pharmakon Advisors, an investor in non-dilutive debt for the life sciences industry and investment manager of the BioPharma credit funds. Banking and finance counsel Tervel Stoyanov (pictured left)
Niederer Kraft Frey (NKF) advised Moving Spine on the funding received to further develop improving standards of care for patients with spinal injuries. NKF’s team Corporate/M&A counsel Thomas Sprecher (pictured right)
Abegg & Co has been granted a license by FINMA to act as manager of collective assets. The license allows the Zurich-based single family office to take over the responsibility for portfolio and risk management
